{"id":2311,"date":"2026-06-11T18:00:00","date_gmt":"2026-06-11T21:00:00","guid":{"rendered":"https:\/\/sevenresiduosaude.com.br\/blog\/?p=2311"},"modified":"2026-06-11T18:00:00","modified_gmt":"2026-06-11T21:00:00","slug":"rss-clinica-medicina-infectologia-comunitaria-dengue-chikungunya-zika-febre-amarela-vacina-acip-sbim-pni","status":"publish","type":"post","link":"https:\/\/sevenresiduosaude.com.br\/blog\/rss-clinica-medicina-infectologia-comunitaria-dengue-chikungunya-zika-febre-amarela-vacina-acip-sbim-pni\/","title":{"rendered":"RSS infecto comu: dengue, zika, vacina"},"content":{"rendered":"

A regula\u00e7\u00e3o brasileira de RSS \u00e9 frequentemente subaproveitada por gestores hospitalares que reduzem RSS a descarte de seringa e gaze<\/strong>. Em 2026, h\u00e1 um cen\u00e1rio desafiador \u2014 hospitais com infectologia comunit\u00e1ria<\/strong> + arboviroses dengue+chikungunya+zika+febre amarela+oropouche<\/strong> + bacterianas leptospirose+meningococo C+B+W135+Y+pneumococo PCV13+PCV20+PPSV23+coqueluche dTpa+t\u00e9tano TdaP<\/strong> + Influenza tetravalente quadrivalente+RSV nirsevimab Beyfortus AstraZeneca\/Sanofi imuniza\u00e7\u00e3o passiva+Abrysvo Pfizer materna+SARS-CoV-2 bivalente+JN.1+KP.2 atualizada+VLP HPV Gardasil 9+Cervarix+ZAB rotav\u00edrus+VOP\/VIP polio+Tr\u00edplice Viral SCR sarampo+caxumba+rub\u00e9ola+VARICELA+hepA+hepB+BCG<\/strong> + vacinas vivas atenuadas+inativadas+subunidade+conjugadas+VLP+mRNA+adenovirais+prote\u00edna recombinante<\/strong> + PNI Programa Nacional Imuniza\u00e7\u00e3o Minist\u00e9rio Sa\u00fade+SBIm+SBP+ACIP CDC<\/strong> geram fluxos heterog\u00eaneos de RSS Grupo A1 (sangue venoso testes serol\u00f3gicos+IgM+IgG+RT-PCR+NS1 dengue+ZIKV+CHIKV+leptospirose MAT) + Grupo A2 (escarro+secre\u00e7\u00e3o respirat\u00f3ria+aerossol PEP) + Grupo B (vacinas viva atenuada+inativada+conjugada+VLP+mRNA+adenoviral+frasco vencido+lote recall+anti-RSV nirsevimab Beyfortus+Abrysvo Pfizer+CoVax+Moderna+Pfizer-BioNTech+Janssen+AstraZeneca+Sinovac CoronaVac+IGHAHB+IGRH+IGTAB+IGT antitet\u00e2nica+IGRAB+IGRAR+IGAB anti-r\u00e1bica+SAT+SCAA+SAAR Lista B\/C5) + Grupo E (perfuro pen+seringa+agulha vacina\u00e7\u00e3o+Vacutainer hemocultura+coleta capilar lanceta).<\/p>\n

Para o gestor que opera ou planeja gest\u00e3o infectologia comunit\u00e1ria hospitalar, \u00e9 fundamental dimensionar RSS espec\u00edfico desde o in\u00edcio.<\/p>\n

Os 5 fluxos infectol\u00f3gicos comunit\u00e1rios<\/h2>\n

Em uma opera\u00e7\u00e3o de qualquer porte, o RSS infecto comunit\u00e1rio tem 5 fluxos.<\/p>\n\n\n\n\n\n\n\n\n\n
Fluxo<\/th>\nVolume<\/th>\nFrequ\u00eancia<\/th>\nParticularidade<\/th>\n<\/tr>\n<\/thead>\n
Arboviroses dengue+ZIKV<\/td>\n4-12 kg\/dia<\/td>\nDi\u00e1ria<\/td>\nNS1+IgM+IgG+RT-PCR<\/td>\n<\/tr>\n
Vacina\u00e7\u00e3o rotineira PNI<\/td>\n5-15 kg\/dia<\/td>\nDi\u00e1ria<\/td>\nGardasil 9+SCR+BCG<\/td>\n<\/tr>\n
Bacterianas+meningoc<\/td>\n2-6 kg\/dia<\/td>\nDi\u00e1ria<\/td>\nLeptospira+meningoco<\/td>\n<\/tr>\n
RSV+influenza+COVID<\/td>\n2-6 kg\/dia<\/td>\nDi\u00e1ria<\/td>\nNirsevimab+Abrysvo<\/td>\n<\/tr>\n
Imunoglobulinas IG+SAT<\/td>\n1-3 kg\/dia<\/td>\nP\u00f3s-procedimento<\/td>\nIGHAHB+SAT antitet\u00e2nica<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

A soma t\u00edpica \u00e9 14-42 kg\/dia<\/strong> em hospital com gest\u00e3o infecto comunit\u00e1ria madura.<\/p>\n

Arboviroses dengue + chikungunya + zika + febre amarela + Qdenga: o est\u00e1gio viral<\/h2>\n

A primeira camada \u00e9 arboviroses. Padr\u00e3o setorial inclui (a) dengue<\/strong> com 4 sorotipos DENV-1+2+3+4 + Aedes aegypti + Aedes albopictus + tropical+subtropical + Brasil epidemia 2026 maior hist\u00f3ria + classifica\u00e7\u00e3o WHO grave dengue hemorr\u00e1gica + plaquetopenia + vazamento plasma + choque DSS dengue shock syndrome; (b) diagn\u00f3stico dengue<\/strong> com NS1 antigen 1-7 dias + IgM 4-10d + IgG 7d+ + RT-PCR PCR espec\u00edfica sorotipos + ELISA + plaquetas+hemat\u00f3crito monitor; (c) vacinas dengue<\/strong> com Dengvaxia Sanofi CYD-TDV serotype recombinante 9-45a + apenas seropositivos + Qdenga TAK-003 Takeda live tetravalente attenuated 4-60a + reduzido hospitaliza\u00e7\u00e3o 90% + PNI Brasil 2024+ rollout 10-14 anos priorit\u00e1rio; (d) chikungunya CHIKV<\/strong> com Aedes aegypti+albopictus + artralgia poliarticular + cr\u00f4nica 30-50% + Ixchiq IXCHIQ Valneva live attenuated FDA 2023 + reduzido sintomas 99%; (e) zika ZIKV+febre amarela+oropouche<\/strong> com ZIKV microcefalia gestante + GBS Guillain-Barr\u00e9 + amarela vacina ATV 17DD Bio-Manguinhos+ATV-IN Sanofi YF-VAX + oropouche emergente Amaz\u00f4nia.<\/p>\n

Hospital com arboviroses+dengue+vacinas maduro escala diagn\u00f3stico precoce NS1+IgM<\/strong> + escala Qdenga TAK-003 reduzido hospitaliza\u00e7\u00e3o 90%<\/strong> + escala PNI rollout 10-14 anos<\/strong>. Como discutimos no post sobre infectologia<\/a>, arboviroses \u00e9 base.<\/p>\n

Vacina\u00e7\u00e3o PNI + ACIP+SBIm+SBP + meningococo+pneumococo+influenza+RSV: o est\u00e1gio preven\u00e7\u00e3o<\/h2>\n

A segunda camada \u00e9 vacina\u00e7\u00e3o. Padr\u00e3o setorial inclui (a) PNI Programa Nacional Imuniza\u00e7\u00e3o Minist\u00e9rio Sa\u00fade<\/strong> com calend\u00e1rio crian\u00e7a+adolescente+adulto+idoso+gestante+profissional sa\u00fade + Bio-Manguinhos+Butantan+Fiocruz produ\u00e7\u00e3o nacional + ACIP CDC EUA Advisory Committee Immunization Practices + SBIm SBP recomenda\u00e7\u00e3o privada complementar; (b) vacinas conjugadas<\/strong> com pneumococo PCV13 Prevnar+PCV15 Vaxneuvance Merck+PCV20 Prevnar 20 Pfizer + pneumococo PPSV23 polysaccharide adulto >65y + meningoc\u00f3cica C MenC + ACWY Menactra+Menveo+MenQuadfi + B 4CMenB Bexsero Trumenba + Hib Haemophilus + DTPa+dTpa+TdaP coqueluche+t\u00e9tano+difteria; (c) vacinas vivas atenuadas<\/strong> com SCR sarampo+caxumba+rub\u00e9ola Tr\u00edplice Viral + VARICELA Varivax+Varilrix + ZOSTER Zostavax+Shingrix Recombinant Subunit GSK + BCG intrad\u00e9rmica RN + VOP polio Sabin oral + ATV 17DD febre amarela; (d) HPV Gardasil 9 Merck nonavalente+Cervarix bivalente GSK+Gardasil 4 quadrivalente<\/strong> + 9-26y priorit\u00e1rio + 27-45y catch-up + meninas+meninos PNI Brasil 9-14a + adultos imunossuprimidos; (e) influenza+RSV+SARS-CoV-2<\/strong> com influenza tetravalente quadrivalente Inactivated+Live + RSV nirsevimab Beyfortus AstraZeneca\/Sanofi RN+lactente+Abrysvo Pfizer materna 24-36 sem GA+>60y idoso + SARS-CoV-2 bivalente+JN.1+KP.2 atualizada Pfizer-BioNTech Comirnaty+Moderna Spikevax+Pfizer XBB+Novavax recombinant.<\/p>\n

Hospital com vacina\u00e7\u00e3o PNI+ACIP+SBIm maduro escala cobertura 95+% PNI calend\u00e1rio<\/strong> + escala HPV PNI Brasil 9-14a 80%<\/strong> + escala RSV nirsevimab Beyfortus reduzido hospitaliza\u00e7\u00e3o 80%<\/strong>. Conex\u00e3o com Lista C5<\/a>.<\/p>\n

Bacterianas leptospirose+meningococo + IGHAHB+SAT+IGRAR+IGT imunoglobulinas: o est\u00e1gio passivo+especial<\/h2>\n

A terceira camada \u00e9 bacterianas+IG. Padr\u00e3o setorial inclui (a) leptospirose<\/strong> com Leptospira interrogans + ratos urina + enchente+chuva + tetraciclina+penicilina + diagn\u00f3stico MAT microscopic agglutination test+ELISA+RT-PCR; (b) meningococo invasivo IMD<\/strong> com Neisseria meningitidis sorogrupo B+C+W135+Y+A+X + epidemia surto + meningite + sepse Waterhouse-Friderichsen + ceftriaxona+penicilina + quimioprofilaxia rifampicina+ciprofloxacino+ceftriaxona contactos; (c) pneumococo invasivo IPD<\/strong> com Streptococcus pneumoniae + meningite+pneumonia+otite + ceftriaxona+vancomicina + Hib Haemophilus influenzae b epiglotite crian\u00e7a PCV obrigat\u00f3ria; (d) imunoglobulinas IG passivas<\/strong> com IGHAHB anti-hepatite B p\u00f3s-exposi\u00e7\u00e3o + SAT soro antitet\u00e2nico t\u00e9tano contamina\u00e7\u00e3o + IGRAB anti-r\u00e1bica humana antiveneno + IGT antitet\u00e2nica + IGRAR anti-rotav\u00edrus + IGAB anti-r\u00e1bica animal raiva canina+silvestre+morcego+saco amarelo+identifica\u00e7\u00e3o Lista C5; (e) antiveneno+SAAR antiaracn\u00eddico+SCAA anticrot\u00e1lico+SCAA antibotul\u00ednico+SAA antiloxosc\u00e9lico+anti-CSAA+escorpi\u00e3o+aranha+serpente<\/strong> Bothrops+Crotalus+Lachesis+Micrurus + Bio-Manguinhos+Butantan+Vital Brazil.<\/p>\n

Hospital com bacterianas+IG maduro escala leptospirose tetraciclina+penicilina<\/strong> + escala meningococo invasivo ceftriaxona+quimioprofilaxia<\/strong> + escala IGHAHB+SAT acidente perfurocortante 24h golden window<\/strong>. Conex\u00e3o com biosseguran\u00e7a<\/a>.<\/p>\n

Tr\u00eas perfis de RSS por capacidade infecto comunit\u00e1ria<\/h2>\n

Hospital sem CCIH+SCIH PNI integrado.<\/strong> 1-2 fluxos. Custo mensal R$ 15.000-40.000<\/strong> mas perda de Qdenga+RSV+nirsevimab+IG+antiveneno.<\/p>\n

Hospital com infecto comunit\u00e1ria m\u00e9dia.<\/strong> 3 fluxos. Custo mensal R$ 30.000-75.000<\/strong>, captura arboviroses+vacina\u00e7\u00e3o+bacterianas.<\/p>\n

Hospital com infecto comunit\u00e1ria completa 5 fluxos.<\/strong> Arboviroses+vacina\u00e7\u00e3o+bacterianas+RSV+IG + integra\u00e7\u00e3o com servi\u00e7os hospitalares<\/a>. Custo mensal R$ 55.000-130.000<\/strong>, efic\u00e1cia 95%, ROI 1.000-3.000% via captura cobertura PNI 95%+ + Qdenga+nirsevimab+Abrysvo + IG passiva 24h golden window.<\/p>\n

Os tr\u00eas erros que aparecem em infecto comunit\u00e1ria<\/h2>\n

O primeiro \u00e9 a subdimensionamento Lista B\/C5 vacinas+IG passivas<\/strong>. Sem segrega\u00e7\u00e3o Dengvaxia+Qdenga+Ixchiq+nirsevimab+Abrysvo+CoVax+Moderna+Pfizer-BioNTech+Sinovac+IGHAHB+SAT+IGRAR+IGT+SCAA+SAA + Lista B\/C5 = n\u00e3o-conformidade ANVISA RDC 222 + risco contamina\u00e7\u00e3o cruzada profissional + impacto financeiro.<\/p>\n

O segundo \u00e9 a mistura arboviroses + vacinas + bacterianas + IG<\/strong>. Confunde rastreabilidade etiologia + impossibilita PNI calend\u00e1rio+ACIP recommendations+SBIm complementar + risco indica\u00e7\u00e3o inadequada (Qdenga vs SAT vs IGRAB anti-r\u00e1bica).<\/p>\n

O terceiro \u00e9 a falta de protocolo IGHAHB+SAT 24h golden window p\u00f3s-acidente<\/strong>. Sem PEP Post-Exposure Prophylaxis HIV+HBV+raiva 24h + IG passiva + vacina\u00e7\u00e3o ativa + soroconvers\u00e3o monitor = risco infec\u00e7\u00e3o transmiss\u00e3o profissional + viola\u00e7\u00e3o NR-32 + risco trabalhista.<\/p>\n

A regula\u00e7\u00e3o de RSS infecto comunit\u00e1ria no Brasil est\u00e1 em fase de moderniza\u00e7\u00e3o t\u00e9cnica acelerada com infectologia comunit\u00e1ria especializada como prioridade. As institui\u00e7\u00f5es que estruturam fluxos completos desde o in\u00edcio \u2014 alinhadas com calend\u00e1rio 2026 de compliance<\/a> \u2014 atravessam o crescimento sem solavanco. Para gestores que precisam alinhar com gest\u00e3o paralela industrial, o portal Seven Res\u00edduos sobre servi\u00e7os completos<\/a> traz a perspectiva integrada. A PNI Minist\u00e9rio Sa\u00fade + SBIm Sociedade Brasileira Imuniza\u00e7\u00f5es<\/a> \u00e9 refer\u00eancia t\u00e9cnica nacional.<\/p>\n

Solicite cota\u00e7\u00e3o RSS infecto comunit\u00e1ria 5 fluxos completos<\/a><\/strong> \u2014 cap\u00edtulo dedicado a arboviroses dengue 4 sorotipos DENV-1\/2\/3\/4+Aedes aegypti+albopictus+NS1+IgM+IgG+RT-PCR+plaquetas+Dengvaxia Sanofi CYD-TDV+Qdenga TAK-003 Takeda live tetravalente 4-60a PNI Brasil 2024 rollout 10-14a+chikungunya CHIKV Ixchiq IXCHIQ Valneva live FDA 2023+zika ZIKV microcefalia+GBS+febre amarela ATV 17DD Bio-Manguinhos+oropouche emergente Amaz\u00f4nia, vacina\u00e7\u00e3o PNI Programa Nacional+Bio-Manguinhos+Butantan+Fiocruz+ACIP CDC+SBIm+SBP+pneumococo PCV13 Prevnar+PCV15 Vaxneuvance Merck+PCV20 Prevnar 20 Pfizer+PPSV23 adulto >65a+meningoc\u00f3cica C MenC+ACWY Menactra+Menveo+MenQuadfi+B 4CMenB Bexsero+Trumenba+Hib+DTPa+dTpa+TdaP+SCR Tr\u00edplice Viral sarampo+caxumba+rub\u00e9ola+VARICELA Varivax+Varilrix+ZOSTER Zostavax+Shingrix Recombinant Subunit GSK+BCG+VOP polio Sabin+HPV Gardasil 9 Merck+Cervarix GSK+Gardasil 4+influenza tetravalente+RSV nirsevimab Beyfortus AstraZeneca\/Sanofi RN+Abrysvo Pfizer materna+SARS-CoV-2 bivalente+JN.1+KP.2+Pfizer-BioNTech Comirnaty+Moderna Spikevax+Novavax recombinant, bacterianas leptospirose tetraciclina+penicilina+MAT+meningococo invasivo IMD ceftriaxona+penicilina+quimioprofilaxia rifampicina+pneumococo+Hib+Waterhouse-Friderichsen, IG IGHAHB anti-hepatite B p\u00f3s-exposi\u00e7\u00e3o+SAT soro antitet\u00e2nico+IGRAB anti-r\u00e1bica+IGT antitet\u00e2nica+IGRAR anti-rotav\u00edrus+SAA antiloxosc\u00e9lico+SCAA anticrot\u00e1lico+SCAA antibotul\u00ednico Bothrops+Crotalus+Lachesis+Micrurus+Bio-Manguinhos+Butantan+Vital Brazil Lista C5.<\/p>\n","protected":false},"excerpt":{"rendered":"

RSS infecto comunit\u00e1ria: dengue+zika+vacina+dengvaxia+Qdenga. Veja.<\/p>\n","protected":false},"author":3,"featured_media":2310,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[2078,3148,873,3149],"class_list":["post-2311","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-compliance-legislacao","tag-dengue","tag-infectologia-comunitaria","tag-pni","tag-vacina"],"_links":{"self":[{"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/posts\/2311","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/comments?post=2311"}],"version-history":[{"count":1,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/posts\/2311\/revisions"}],"predecessor-version":[{"id":4378,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/posts\/2311\/revisions\/4378"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/media\/2310"}],"wp:attachment":[{"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/media?parent=2311"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/categories?post=2311"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/tags?post=2311"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}